CompletedNot applicableNCT02568527

Biodegradable Synthetic Scaffold as a Substitute for hAM in Limbal Epithelial Cells Transplant in LSCD Patients

Studying Limbal stem cell deficiency

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Virender S Sangwan, MBBS, MS
Principal Investigator
Virender S Sangwan, MBBS MS
LV Prasad Eye Institute
Intervention
PLGA scaffold(device)
Enrollment
5 target
Eligibility
18-70 years · All sexes
Timeline
20152018

Study locations (1)

Collaborators

Wellcome Trust · University of Sheffield

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02568527 on ClinicalTrials.gov

Other trials for Limbal stem cell deficiency

Additional recruiting or active studies for the same condition.

See all trials for Limbal stem cell deficiency

← Back to all trials